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hypothesized that ureaplasma colonization of amniotic fluid will modulate chorioamnionitis induced 
by E.coli lipopolysaccharide (LPS). 
Methods: Sheep received intra-amniotic (IA) injections of media (control) or live ureaplasma either 7 
or 70d before delivery. Another group received IA LPS 2d before delivery. To test for interactions, 
U.parvum exposed animals were challenged with IA LPS, and delivered 2d later. All animals were 
delivered preterm at 125±1 day gestation. 
Results: Both IA ureaplasmas and LPS induced leukocyte infiltration of chorioamnion. LPS greatly 
increased the expression of pro-inflammatory cytokines and myeloperoxidase in leukocytes, while 
ureaplasmas alone caused modest responses. Interestingly, 7d but not 70d ureaplasma exposure 
significantly downregulated LPS induced pro-inflammatory cytokines and myeloperoxidase expression 
in the chorioamnion. 
Conclusion: U.parvum can suppress LPS induced experimental chorioamnionitis. 
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Condensation:  
 
Exposure to intraamniotic Ureaplasma parvum downregulates the inflammatory 
response to intraamniotic injection of Eshcerichia coli endotoxin in the chorioamnion of 
sheep. 
 
 
 
 
Short title:  
 
Ureaplasma modulation of LPS induced chorioamnionitis 
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 ABSTRACT 
Objective: Ureaplasma parvum colonization in the setting of polymicrobial flora is 
common in women with chorioamnionitis, and is a risk factor for preterm delivery and 
neonatal morbidity. We hypothesized that ureaplasma colonization of amniotic fluid will 
modulate chorioamnionitis induced by E.coli lipopolysaccharide (LPS). 
Methods: Sheep received intra-amniotic (IA) injections of media (control) or live 
ureaplasma either 7 or 70d before delivery. Another group received IA LPS 2d before 
delivery. To test for interactions, U.parvum exposed animals were challenged with IA 
LPS, and delivered 2d later. All animals were delivered preterm at 125±1 day gestation. 
Results: Both IA ureaplasmas and LPS induced leukocyte infiltration of chorioamnion. 
LPS greatly increased the expression of pro-inflammatory cytokines and 
myeloperoxidase in leukocytes, while ureaplasmas alone caused modest responses. 
Interestingly, 7d but not 70d ureaplasma exposure significantly downregulated LPS 
induced pro-inflammatory cytokines and myeloperoxidase expression in the 
chorioamnion. 
Conclusion: U.parvum can suppress LPS induced experimental chorioamnionitis. 
 
Word count: 150 
 
 
 
Key words: Endotoxin tolerance, Preterm labor, Innate immunity, Fetal adaptation. 
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Introduction:  
 Premature birth is a major national health concern as it contributes 
disproportionately to neonatal morbidity and mortality, accounting for 12.3% of live-
births and >60% of neonatal deaths in the United States 1. Both clinical and 
experimental studies strongly demonstrate a causal link between intrauterine infection 
and preterm labor 2, 3. The most common organisms isolated from the amniotic fluid of 
women with chorioamnionitis are the Ureaplasma species 4. Furthermore, among the 
preterm infants with chorioamnionitis caused by the Ureaplasma spp., about 60% also 
had co-infection with other organisms 4. Exposure of preterm infants to ureaplasmas is 
associated with increased risk for adverse pulmonary, gastrointestinal and neurological 
outcomes 5. 
Despite the reports demonstrating adverse outcomes, ureaplasma infection often 
is silent clinically.   Ureaplasma spp. have been isolated in amniotic fluid samples from 
genetic amniocenteses done at 15-21 weeks gestation 6, 7. Although the rates of 
preterm deliveries were higher in women with second trimester Ureaplasma spp. in the 
amniotic fluid, the majority of the women delivered at term gestation. The reasons why 
some pregnancies with chronic ureaplasma infection result in preterm delivery while 
others deliver at term are unknown. There is minimal information on modulation of 
innate immune system of the maternal or fetal host by the Ureaplasma spp. 
  We reported that intraamniotic injection of U.parvum in sheep induced a chronic 
colonization with poor host clearance of the organism from the amniotic fluid 8. 
Interestingly, chronic but not acute infection of amniotic fluid with ureaplasmas 
suppressed E. Coli endotoxin (LPS) induced inflammation in the fetal lung, indicating 
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innate immune tolerance 9. Further, we previously demonstrated that multiple exposures 
to intraamniotic LPS also induced endotoxin tolerance in the preterm fetus 10, 11. We 
therefore hypothesized that chronic but not acute exposure to ureaplasmas will down-
regulate LPS induced chorioamnionitis. We report inflammatory responses in the 
chorioamnion to intraamniotic exposures to acute and chronic ureaplasmas, to LPS and 
the interactions between ureaplasma and LPS exposures.   
   
Materials and Methods: 
Animals and Intra-Amniotic Injections 
 All animals were studied in Western Australia with approval from the animal 
ethics/care and use committees of the Cincinnati Children’s Hospital Medical Center 
(Cincinnati, OH) and the University of Western Australia. The fetal pulmonary data from 
these animals were previously reported 9. Time-mated Merino ewes with singleton 
fetuses were randomly assigned to six groups of 5 to 10 animals (Figure 1). All 
injections were given by the intra-amniotic (IA) route under ultrasound guidance, and 
after verification of proper placement in the amniotic compartment by fluid electrolyte 
analysis of aspirated samples 12. Sheep received an IA injection of 1) U. parvum serovar 
3 (2 x 107 CFU) or 2 mL media as a control 70 days or 7 days prior to delivery, 2) 
Escherichia coli LPS (O55:B5; Sigma-Aldrich, St. Louis, MO) 10 mg in 2 mL saline or 
saline only as a control 2 days prior to delivery. To evaluate the interactions, sheep 
were given IA injections of U. parvum 7d or 70d prior to delivery plus IA LPS 2 days 
before delivery. Animals were delivered by cesarean section at 125 ± 1 day gestational 
age (term ewe gestation = 150 days). Fetuses were given lethal intravascular doses of 
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pentobarbital for euthanasia. At the time of delivery, rolls of fetal chorioamniotic 
membranes were snap-frozen for RNA analysis, and a roll was fixed in 10% buffered 
formalin (pH 7.4) for histology. A fresh sample of amniotic fluid was used for pH 
measurement. Amniotic fluid was also snap-frozen for measurement of cytokine 
proteins. The presences of ureaplasmas within sheep chorioamnion was confirmed by 
culture of homogenized tissue in 10B broth medium using previously reported protocols 
13, 14. 
Immunohistochemistry and Scoring of Inflammation 
 Inflammatory cells in the chorioamnion were quantified by immunohistochemistry 
for markers of inflammatory cell activation using 5 µm paraffin sections from formalin 
fixed chorioamnion. The sections were de-paraffinized and rehydrated, and antigen-
retrieval was carried out using citric acid buffer, pH 6.0, with microwave boiling. 
Endogenous peroxidase activity was blocked with methyl alchohol/hydrogen peroxide. 
Nonspecific binding was inhibited with 2% goat serum during both primary and 
secondary antibody incubation. Sections were incubated overnight at 4ºC with anti-
myeloperoxidase (MPO) antibody (1:400) (Cell marque, Rocklin, California, catalogue # 
CMC028), or guinea-pig polyclonal anti-monocyte chemoattractant protein (MCP)-1 
antibody (1:1000) generated at our institution (Seven Hills Bioreagents, Cincinnati, OH). 
After washing, sections were incubated with the appropriate secondary antibody for 30 
minutes at room temperature (1:200). Immunostaining was visualized using a 
Vectastain ABC peroxidase Elite kit abd enhanced with nickel-diaminobenzidine, 
followed by incubation with TRIS-cobalt to give a black precipitate. Nuclei were 
counterstained with Nuclear Fast Red for photomicroscopy. Scoring of MPO and MCP-1 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 7 
positive cells in 10 comparable non-overlapping high-power fields for each animal was 
done by a single investigator blinded to study groups. For qualitative scoring of 
chorioamnionitis, the sections were stained with hemotoxylin and eosin, and staged and 
graded for degree of inflammation in a blinded manner using a modified Redline grading 
system 15. Scores denoting the magnitude and tissue distribution of neutrophil infiltration 
within the chorionamnion were reported as follows: Score 0= No chorioamnionitis, Score 
1 = Stage 1, Grade 1 chorioamnionitis, Score 2 = Stage 1, Grade 2 chorioamnionitis, 
Score 3 = Stage 2, Grade 2 chorioamniontis, and score 4 = Stage 3, Grade 2 
chorioamnionitis.  
Cytokine mRNA Quantitation 
 Total RNA was isolated from the frozen chorioamnion samples using a modified 
Chomczynski method 9. The quantitation of mRNA was performed by real-time 
polymerase chain reaction (PCR) after reverse transcription of the mRNA yielding a 
single-strand complementary DNA (cDNA) (Verso cDNA kit, Thermo Scientific, 
Waltman, MA). cDNA was then used as a template with primers and TaqMan probes 
(Applied Biosystems, Carlsbad, CA) specific to sheep sequences for interleukin (IL)-1β, 
IL-6, IL-8, IL1-RA, MCP-1 and serum amyloid A3 (SAA3) 16. The values for each 
cytokine were normalized to the internal 18s ribosomal RNA (rRNA) value. Final 
expression data are represented as fold increase over the control value.  
Amniotic Fluid Protein Analysis 
 Cytokine protein quantification was performed using custom sandwich enzyme-
linked-immunosorbent assay (ELISA) 17, 18.  The following antibody sets were used: 1) 
IL-1β [coating Ab: rabbit anti-ovine IL-1β and primary Ab guinea-pig anti-ovine IL-1β 
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 8 
(Seven Hills Bioreagents)], and 2) IL-6 [coating Ab: mouse anti-ovine IL-6 (Chemicon # 
MAB1004) and primary Ab rabbit anti-ovine IL-6 (Chemicon #AB1839)]. The detection 
antibody in all assays was an appropriate species-specific HRP-conjugated antibody. 
The dynamic range of detection was 0.2-12 ng/mL for IL-1β and IL-6. The correlation 
coefficient was 0.94-0.99 for all assays. 
Data Analysis 
 Results are reported as mean ± SEM. All comparisons were specified a priori. 
Comparisons among three or more groups were performed by Kruskal-Wallis non-
parametric analyses of variance (ANOVA). Comparison of two groups was done by a 
nonparametric t test (Mann-Whitney U test) for data not normally distributed (GraphPad 
Prism, version 5.04 for Windows La Jolla, California). The control group was compared 
versus 7d UP, 70d UP, and 2d LPS. To specifically examine the effect of U.parvum 
infection on LPS response, 2d LPS was compared versus 7d UP+ 2d LPS, and 70d UP 
+ 2d LPS. Statistical significance was accepted at p<0.05.  
Results: 
 
 Intra-amniotic infection with U.parvum did not cause any gross fetal 
developmental abnormalities or mortality. Consistent with ureaplasma utilizing urea as a 
nutritional source with liberation of ammonia, the amniotic fluid pH values differed 
significantly among groups (p=0.01), and was significantly higher in the 70 day 
U.parvum group when compared to controls (Figure 2).   
Histological chorioamnionitis after intra-amniotic injections of LPS and U.parvum  
 To evaluate the degree of histologic chorioamnionitis among groups, the 
infiltration of neutrophils in the chorioamnion were scored qualitatively (Figure 3). 
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Relative to the control, all treatment groups had significantly increased recruitment of 
neutrophils and higher scores for chorioamnionitis (p=0.004), but there were no 
differences between the LPS and U.parvum groups.  
 To further evaluate the activation of inflammatory cells in the chorioamnion, 
myeloperoxidase (MPO) in the inflammatory cells was quantified (Figure 4). Relative to 
controls, MPO positive cells significantly increased in all groups except in those sheep 
with acute U.parvum + LPS exposure. Compared to LPS exposure alone, MPO positive 
cells significantly decreased in the 7 day U.parvum + LPS group, but chronic U.parvum 
exposure did not have significant interaction with LPS effects.   
Acute exposure to U. parvum down-regulated LPS-induced cytokine expression in the 
chorioamnion/amniotic fluid. 
 We previously demonstrated that the chorioamnion is a target of inflammation 
after exposure to intraamniotic (IA) administration of pro-inflammatory agonists 19. We 
therefore measured expression of pro-inflammatory cytokine, chemokine, acute phase 
reactant and anti-inflammatory cytokine mRNAs in the chorioamnion (Figure 5 A-F). 
Relative to controls, acute (7 d exposure) did not increase cytokine mRNA expression 
while chronic (70 d exposure) to U.parvum induced increases in mRNA expression for 
IL-1β (35 fold), IL-6 (34 fold), IL-8 (31 fold), SAA3 (300 fold), and IL-1RA (5 fold). In 
contrast, exposure to IA LPS for 2 d greatly increased expression of both the pro-
inflammatory cytokines/chemokines: IL-1β (148 fold), IL-6 (30 fold), IL-8 (246 fold), 
MCP-1 (336 fold), SAA3 (800 fold), and the anti-inflammatory cytokine IL-1ra (14 fold). 
Prior exposure to U.parvum for 70 d did not consistently change responses to LPS 
(MCP-1 mRNA decreased compared to LPS alone, while IL-1ß, IL-6, IL-8, SAA3 and IL-
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1ra did not). In sharp contrast, acute exposure to U.parvum (7d), significantly and 
consistently down-regulated LPS responses to near control levels.  
To further confirm these findings, we measured IL-1ß and IL-6 protein levels in 
the amniotic fluid. Neither acute nor chronic exposure to U.parvum alone increased 
secretion of IL-6 (Figure 6A) or IL-1ß (Figure 6B) in the amniotic fluid. Consistent with 
the mRNA responses, IA LPS increased IL-1ß and IL-6 secretion. Similar to the mRNA 
effects, acute but not chronic prior exposure to U.parvum decreased LPS mediated 
induction of IL-6. There were non-significant trends to decrease LPS induced IL-1ß 
expression with prior acute (p=0.3) or chronic (p=0.06) U.parvum exposure. 
To begin to get mechanistic insights, we measured the mRNA expression of the 
toll-like receptors in the chorioamnion that signal LPS responses (TLR4) and U.parvum 
responses (TLR2 and TLR6) 20. The chronic but not acute exposure to U.parvum 
increased expression of TLR 2 (12 fold), TLR4 (3 fold) or TLR6 (2 fold) (Figure 7A-C). 
LPS alone also increased expression for TLR2 (8 fold) and TLR4 (2 fold). Interestingly, 
compared to the 2d LPS group, the TLR4 mRNA expression did not increase in the 7d 
UP+2d LPS group. In contrast, there were no significant differences in the TLR 
expression between the 2d LPS group vs. 70d UP+2d LPS group. 
Discussion: 
 We report a novel finding that Ureaplasma spp. infection of the amniotic cavity 
can profoundly suppress signaling by LPS, a constituent of the cell wall of Gram-
negative bacteria. Microbial invasion of amniotic cavity is relatively unique among 
infectious diseases in humans: The microbes responsible are mostly opportunistic 
pathogens in otherwise healthy women, polymicrobial growth is common, and 
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Ureaplasma spp. that rarely cause infections elsewhere are the most common organism 
21, 22.  The interactions between Ureaplasma spp. and other microbial products in this 
polymicrobial mileu have not been studied. Adding to the intrigue, chorioamnionitis has 
been associated with variable outcomes ranging from no pathology to the mother or the 
fetus to significant morbidity to the mother/fetus 5, 23, 24. Our results offer a possible 
explanation for the variable inflammation in chorioamnionitis in the setting of multiple 
microbial products in the amniotic cavity.  
 Endotoxin tolerance resulting in suppressed LPS signaling causes a complex re-
programming of inflammatory responses 25. Pro-inflammatory cytokine expression is 
down regulated, while there is no change or even an increase in the expression of anti-
inflammatory genes, antimicrobial genes, genes mediating phagocytosis 25. The net 
result of endotoxin tolerance appears to prevent host organ injury while maintaining 
antimicrobial functions. However, almost all the information regarding endotoxin 
tolerance is derived from gene expression studies in vitro in functionally mature 
monocytes or macrophages. The genes reported not to be down regulated after 
endotoxin tolerance include IL-10, IL-1ra, TGFß1, serum amyloid and others 26. In our 
study, the upregulation of TLR4 expression after IA LPS exposure was prevented by 
prior exposure to a 7d U.parvum exposure. IL-1ra and serum amyloid A3 gene were 
also down regulated similar to the other pro-inflammatory cytokines in the acute (7d) 
U.parvum +LPS exposed fetuses. Similarly, the activation of inflammatory cells as 
indicated by myeloperoxidase expression also decreased in the acute (7d) U.parvum 
+LPS fetuses, relative to the LPS alone exposed animals. These results suggest that 
acute exposure to U.parvum induced down regulation of LPS responses were more 
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global in nature than previously reported in endotoxin tolerance in vitro 26 and could be 
partially modulated by changing the toll-like receptor gene expression.  
 Since endotoxin tolerance is an adaptive host response, the characteristics of 
endotoxin tolerance might vary depending on the inflammatory context. We previously 
reported that preterm sheep fetuses exposed to repeated doses of intraamniotic LPS 
demonstrate endotoxin tolerance and cross-tolerance to other toll-like agonists 10, 27. 
Further, we recently reported that chronic (70d) but not acute (7d) exposure to 
U.parvum suppressed LPS signaling in the fetal lung. In contrast to the lung findings 
and our hypothesis, we found a consistent suppression of LPS induced inflammatory 
responses in the chorioamnion of the acute (7d) ureaplasma exposed animals. 
Interestingly, relative to the LPS alone group, the chronic (70d) + LPS group had an 
inconsistent suppression of LPS induced pro-inflammatory cytokine gene expression. 
Manimtim et al 28 reported that lower doses of ureaplasmas inhibited LPS induced IL-6 
secretion by blood monocytes from preterm infants in in vitro studies, while higher 
doses augmented LPS responses. These divergent responses may be due to the in 
vivo responses of the chorioamnion, while studies by Manimtim et al were in vitro 
experiments using blood monocytes. Taken together, these experiments demonstrate 
that ureaplasmas can modulate LPS responses in a time and tissue dependent manner. 
The gold standard for diagnosis of chorioamnionitis is histological evidence of 
inflammatory cell infiltration 15. However the organ injury is caused by products of 
inflammation e.g. cytokines and prostaglandins. Therefore, the pathophysiology of 
inflammation-induced damage requires recruitment of inflammatory cells, followed by 
activation and elaboration of products of inflammation. Interestingly, our data 
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demonstrate that  exposure to ureaplasmas alone or LPS exposure alone induced 
histological chorioamnionitis. However, despite the presence of histological 
chorioamnionitis, relative to the LPS only group, the 7d ureaplasma + 2d LPS exposure 
group had suppressed cytokine expression and very few myeloperoxidase expressing 
cells in the chorioamnion, indicating that the inflammatory cells were not activated. 
These results demonstrate that ureaplasmas selectively suppress LPS induced 
inflammatory cell activation in the chorioamnion but not the recruitment.  
 Microbial load has been postulated to be a determinant of the severity of 
chorioamnionitis 29. However, we previously reported that in sheep whose amniotic 
cavity was inoculated with  U. parvum  serovar 6, there was a chronic colonization with 
poor clearance of the organism that persisted for more than 12 weeks post inoculation 8. 
Consistent with our previous results demonstrating chronic colonization, we observed in 
these animals, no significant differences in the colony counts of ureaplasmas 7d or 70d 
after intramniotic injection of 2 x 107 CFU 9. Nevertheless, chronic U.parvum infection 
increased the pH of the amniotic fluid, while acute infection did not. The increase in pH 
generated by ureaplasmas within amniotic fluid may limit the numbers of CFUs within 
the body fluid just as ureaplasma growth in vitro is limited by the generation of ammonia 
as an end product of metabolism.   Therefore increased amniotic fluid pH may serve as 
a biomarker of chronicity of U.parvum infection. In the present study, there was minimal 
inflammation in the chorioamnion with 7d exposure to ureaplasmas, but with 70d 
chronic exposure there was a modest but discernable increase in pro-inflammatory 
cytokine expression and myeloperoxidase expression in the choriomnion. 
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Our data have several clinical implications. Although Ureaplasma spp are the 
organisms most commonly associated with chorioamnionitis, recent studies have 
confirmed the polymicrobial flora in many cases of chorioamnionitis 4, 30. Our findings 
suggest the possibility of decreased fetal inflammation in response to Gram-negative 
organisms with concomitant ureaplasma exposure. Since the timing of ureaplasma 
infections is not known in clinical cases, our findings of endotoxin tolerance with acute 
but not chronic ureaplasma infection also underline the complexity of interactions and 
difficulty in predicting severity of chorioamnionitis in women with mixed flora. Adults with 
sepsis have diminished innate immune responses 31. Postnatal nosocomial sepsis 
occurs in about 25% of very low birth weight preterm neonates 32. Possibly, ureaplasma 
chorioamnionitis could diminish innate immune responses and thereby increase the 
susceptibility of preterm infant to nosocomial sepsis.  
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Figure legends: 
Figure 1. Schematic of the experimental design. The different study groups with the 
interventions along with the sample size is shown. All injections were given by the 
intraamniotic route and the timing in gestational days is shown. Open arrow indicates 
either media or saline, grey arrow indicates U.parvum  and black arrow indicates LPS 
injection. (Term gestation=150d in sheep). 
Figure 2. Chronic U.parvum infection increases amniotic fluid pH. The pH of the 
amniotic fluid was measured at autopsy. 70d exposure but not 7d exposure to U.parvum 
increased the pH of amniotic fluid (*p< 0.05 versus controls). 
Figure 3. Staging of Chorioamnionitis after intra-amniotic injections of LPS and 
U.parvum. (A) Blind scoring for severity of chorioamnionitis was performed using a 
modified Redline staging method. Representative photomicrographs showing 
hematoxylin and eosin staining of chorioamnion sections from  (B) controls, (C) 2 day 
LPS, and (D) 7 day U.parvum + 2 day LPS. Arrows point to inflammatory cells at the 
junction of amnion and chorion (*p< 0.05 versus controls). 
Figure 4. Acute amniotic exposure to U. parvum decreased intra-amniotic LPS-
induced myeloperoxidase (MPO) expression. (A) Quantitation of MPO-positive cells 
per microscopic high-power field is shown. Representative photomicrographs are shown 
for MPO immunostaining in (B) controls, (C) 2 day LPS, and (D) 7 day U.parvum + 2 
day LPS. Arrows point to inflammatory cells in the chorion in panel C (*p< 0.05 versus 
controls. 
#
p< 0.05 versus 2 day LPS). 
Figure 5. Acute exposure to U. parvum down-regulated LPS-induced cytokine 
mRNA expression in the chorioamnion. Quantification of messenger RNAs for (A) IL-
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1β, (B) IL-6, (C) IL-8, (D) MCP-1, (E) serum amyloid A3 and (F) IL-1 receptor antagonist 
was performed by real-time PCR assays using sheep-specific primers and TaqMan 
probes. Each cytokine was normalized to 18s ribosomal protein mRNA (internal 
control), and levels for each group were expressed relative to controls as fold increase 
relative to controls. (*p< 0.05 versus controls, 
#
p< 0.05 versus 2 day LPS). 
Figure 6. Acute exposure to U. parvum down-regulated LPS-induced cytokine 
proteins in the amniotic fluid. Cytokine proteins in the amniotic fluid were measured 
by ELISA , (A) IL-6 and (B) IL-1β. (*p < 0.05 versus controls. 
#
p < 0.05 versus 2 day 
LPS). 
Figure 7. Acute exposure to U. parvum down-regulated LPS-induced TLR mRNA 
expression in the chorioamnion. Quantification of messenger RNAs for (A) TLR2, (B) 
TLR4, and (C) TLR6 was performed by real-time PCR assays using sheep-specific 
primers and TaqMan probes. Each cytokine was normalized to 18s ribosomal protein 
mRNA (internal control), and levels for each group were expressed relative to controls 
as fold increase relative to controls. (*p< 0.05 versus controls, 
#
p< 0.05 versus 2 day 
LPS). 
 
 
C-Section at 
125 days GA 
55 days   118 days 
Control	  
Media/Sal	  
7d	  UP	  
123 days 
Group	   Animal  
Number 
70d	  UP	  
2d	  LPS	  
7d	  UP	  
+2d	  LPS	  
70d	  UP	  
+2d	  LPS	  
7
6
5
10 
7 
5 
Figure 1 
Figure 1
6.8
6.9
7.0
7.1
7.2
7.3
7.4
7.5
*
Figure 2 
U
ni
ts
 
  C    7dUP  70dUP 2dLPS  7dUP  70dUP 
                                         +2dLPS +2dLPS 
Amniotic fluid pH 
Figure 2
  C    7dUP  70dUP 2dLPS  7dUP  70dUP 
                                         +2dLPS +2dLPS 
Sc
or
e 
Chorioamnion H&E 
Figure 3 
A 
0
1
2
3
4
*
*
* *
*
50µm	  
Amnion	  
Chorion	  
D  7d UP+ 2d LPS 
  
Amnion	  
Chorion	  
C  2d LPS 
  
Amnion	  
Chorion	  
B   Control 
  
Figure 3
  C    7dUP  70dUP 2dLPS  7dUP  70dUP 
                                         +2dLPS +2dLPS 
Figure 4 
0
20
40
60
80
100
*
*
* #
*
C
el
ls
/H
PF
 
Chorioamnion MPO+ cells 
A 
50µm	  
B   Control 
  
Amnion	  
Chorion	  
D  7d UP+ 2d LPS 
  
Amnion	  
Chorion	  
C  2d LPS 
  
Chorion	  
Figure 4
  C    7dUP  70dUP 2dLPS  7dUP  70dUP 
                                         +2dLPS +2dLPS 
Figure 5 
0
50
100
150
200
*
#
*
*
IL-1ß 
Fo
ld
 In
cr
ea
se
 
A 
0
20
40
60
*
* #
**
IL-6 
B 
0
100
200
300
400
* * #
*
IL-8 
Fo
ld
 In
cr
ea
se
 
C 
0
100
200
300
400
500
* #
*
#
MCP-1 
D 
E 
0
10
20
30
40
*
*
IL-1RA 
F 
0
500
1000
1500
* #
*
* *
  C    7dUP  70dUP  2dLPS   7dUP   70dUP 
                                           +2dLPS +2dLPS 
SAA3 
Fo
ld
 In
cr
ea
se
 
Figure 5
  C    7dUP  70dUP 2dLPS  7dUP  70dUP 
                                         +2dLPS +2dLPS 
  C    7dUP  70dUP 2dLPS  7dUP  70dUP 
                                         +2dLPS +2dLPS 
Figure 6 
0.0
0.5
1.0
1.5
5
10
15
 #
*
*
ng
/m
L 
AF  IL-6 
A 
0
1
2
3
4
5
*
AF IL-1ß 
B 
Figure 6
0.0
0.5
1.0
1.5
2.0
2.5
* *
0
1
2
3
4
#
*
*
0
5
10
15
20
* 
*
* *
  C    7dUP  70dUP  2dLPS   7dUP   70dUP 
                                           +2dLPS +2dLPS 
Fo
ld
 In
cr
ea
se
 
Figure 7 
Fo
ld
 In
cr
ea
se
 
A B 
C 
  C    7dUP  70dUP  2dLPS   7dUP   70dUP 
                                           +2dLPS +2dLPS 
TLR2 TLR4 
TLR6 
Figure 7
